Pacific Life Foundation Announces $2.75 Million in Grants to Nearly 200 Nonprofit Agencies in Southern California …
Pacific Life Foundation Announces $2.75 Million in Grants to Nearly 200 Nonprofit Agencies in Southern California …
The Pacific Life Foundation announced $2.75 million in grants, ranging from $5,000 to $100,000, to nearly 200 nonprofit agencies serving Southern California during an early Monday evening reception.
Read more on Business Wire via Yahoo! Finance
Categories: Breast Cancer Organizations Tags: $2.75, Agencies, Announces, California, Foundation, Grants, Life, million, Nearly, nonprofit, Pacific, Southern
Xoft Awarded Two Qualifying Therapeutic Discovery Project Program Grants For Electronic Brachytherapy
Xoft Awarded Two Qualifying Therapeutic Discovery Project Program Grants For Electronic Brachytherapy
Xoft, Inc., developer of the Axxent® Electronic Brachytherapy, eBx⢠System, announced today that it has received nearly $500,000 in grants from the Qualifying Therapeutic Discovery Project Program.  Xoft received the maximum amount of $244,479.25 for two Electronic Brachytherapy grants, one for the treatment of breast cancer and one for the treatment of gynecological cancers.  The …
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Treatment Tags: awarded, Brachytherapy, Discovery, Electronic, Grants, program, Project, Qualifying, Therapeutic, XOFT
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal …
FDA Grants Priority Review Designation to Denosumab Biologics License Application for the Reduction of Skeletal …
Amgen today announced that the U.S. Food and Drug Administration has granted priority review designation to denosumab, a subcutaneous RANK Ligand inhibitor, for the treatment of bone metastases to reduce skeletal related events in patients with cancer.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Risks Tags: application, Biologics, Denosumab, Designation, Grants, License, priority, reduction, Review, Skeletal
FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder
FDA grants orphan drug designation to pralatrexate for treatment of advanced TCC of urinary bladder
Allos Therapeutics, Inc. announced today that the U.S. Food and Drug Administration has granted orphan drug designation to pralatrexate for the treatment of advanced or metastatic transitional cell carcinoma of the urinary bladder, a form of bladder cancer. The Company is currently investigating pralatrexate in a Phase 2 clinical study in patients with advanced or metastatic relapsed TCC of the …
Read more on News-Medical-Net
Categories: Breast Cancer Treatment Tags: advanced, Bladder, Designation, drug, Grants, Orphan, pralatrexate, Treatment, urinary
CPRIT Funds First Cancer Prevention Grants
CPRIT Funds First Cancer Prevention Grants
The Cancer Prevention and Research Institute of Texas (CPRIT) today awarded over $6.8 million to fund twelve new cancer prevention programs through local clinics, health districts, community-based organizations, and academic institutions across the state of Texas. This is the very first round of prevention grants awarded in CPRIT’s 10-year, $3 billion mission. “It all starts with prevention and …
Read more on Medical News Today
Categories: Breast Cancer Research Tags: cancer, CPRIT, first, funds, Grants, Prevention